omeprazole IV
Selected indexed studies
- Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats. (Pharm Biol, 2019) [PMID:31290355]
- Pantoprazole. (Am J Health Syst Pharm, 2001) [PMID:11402494]
- Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract. (JAMA Surg, 2018) [PMID:29365025]
_Worker-drafted node — pending editorial review._
Connections
omeprazole IV is a side effect of
Sources
- Pantoprazole. (2001) pubmed
- New Drugs IV. (1994) pubmed
- Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats. (2019) pubmed
- Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract. (2018) pubmed
- Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial. (2006) pubmed
- A new concept regarding the mechanism of action of omeprazole. (1999) pubmed
- Omeprazole prevents stress induced gastric ulcer by direct inhibition of MMP-2/TIMP-3 interactions. (2022) pubmed
- Effect of omeprazole on oral and intravenous RS-methadone pharmacokinetics and pharmacodynamics in the rat. (2002) pubmed
- Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome. (1991) pubmed
- Efficacy and safety of nitazoxanide based quadruple regimen as first line therapy for treating Helicobacter pylori infected naïve patients. (2025) pubmed